TY - JOUR T1 - Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation JF - Gastroenterology Y1 - 2015 A1 - M R Charlton A1 - E J Gane A1 - Manns, M.P. A1 - R S Brown Jr. A1 - M P Curry A1 - P Y Kwo A1 - Robert J Fontana A1 - Gilroy, R. A1 - Teperman, L. A1 - Muir, A.J. A1 - J G McHutchison A1 - Symonds, W.T. A1 - Brainard, D. A1 - B J Kirby A1 - Dvory-Sobol, H. A1 - Denning, J. A1 - Arterburn, S. A1 - Samuel, D. A1 - Forns, X. A1 - N A Terrault KW - Anemia KW - Biopsy KW - Boston KW - California KW - Cities KW - Creatinine KW - Death KW - Diarrhea KW - Fatigue KW - France KW - Genotype KW - genotype 1 KW - Germany KW - HCV KW - Headache KW - hepatitis KW - Hepatitis C KW - hepatitis C virus KW - Immunosuppressive Agents KW - Infection KW - interferon KW - Israel KW - Liver KW - Liver Transplantation KW - Male KW - Massachusetts KW - Medicine KW - methods KW - Michigan KW - Minnesota KW - New York KW - New Zealand KW - North Carolina KW - Paris KW - Patients KW - resistance KW - Ribavirin KW - Safety KW - San Francisco KW - secondary KW - sofosbuvir KW - Spain KW - sustained virologic response KW - therapy KW - transplantation KW - treatment KW - Universities VL - 148 SP - 108-117 IS - 1 ER -